Research ArticleOriginal Article

Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030

Shaoyuan Lei, Rongshou Zheng, Siwei Zhang, Ru Chen, Shaoming Wang, Kexin Sun, Hongmei Zeng, Wenqiang Wei and Jie He
Cancer Biology & Medicine August 2021, 18 (3) 900-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0523

References

  1. 1.↵
    2. Bray F,
    3. Ferlay J,
    4. Soerjomataram I,
    5. Siegel RL,
    6. Torre LA,
    7. Jemal A.
    Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2018; 68: 394–424.
    OpenUrlCrossRefPubMed
  2. 2.↵
    2. Fan L,
    3. Zheng Y,
    4. Yu KD,
    5. Liu GY,
    6. Wu J,
    7. Lu JS, et al.
    Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat. 2009; 117: 409–16.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    2. Zheng RS,
    3. Sun KX,
    4. Zhang SW,
    5. Zeng HM,
    6. Zou XN,
    7. Chen R, et al.
    Report of cancer epidemiology in China, 2015. Zhonghua Zhong Liu Za Zhi. 2019; 41: 19–28.
    OpenUrlCrossRefPubMed
  4. 4.↵
    2. Chen W,
    3. Zheng R,
    4. Baade PD,
    5. Zhang S,
    6. Zeng H,
    7. Bray F, et al.
    Cancer statistics in China, 2015. CA: Cancer J Clin. 2016; 66: 115–32.
    OpenUrlCrossRefPubMed
  5. 5.
    2. Chen W,
    3. Zheng R.
    Incidence, mortality and survival analysis of breast cancer in China. Chin J Clin Oncol. 2016; 42: 668–74.
    OpenUrl
  6. 6.
    2. Bray F,
    3. Mc Carron P,
    4. Parkin DM.
    The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004; 6: 229–39.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.
    2. Fan L,
    3. Strasser-Weippl K,
    4. Li JJ,
    5. St Louis J,
    6. Finkelstein DM,
    7. Yu KD, et al.
    Breast cancer in China. Lancet Oncol. 2014; 15: 279–89.
    OpenUrl
  8. 8.↵
    2. Yanhua C,
    3. Geater A,
    4. You J,
    5. Li L,
    6. Shaoqiang Z,
    7. Chongsuvivatwong V, et al.
    Reproductive variables and risk of breast malignant and benign tumours in Yunnan province, China. Asian Pacific J Cancer Prevent. 2012; 13: 2179–84.
    OpenUrl
  9. 9.↵
    2. Petracci E,
    3. Decarli A,
    4. Schairer C,
    5. Pfeiffer RM,
    6. Pee D,
    7. Masala G, et al.
    Risk factor modification and projections of absolute breast cancer risk. J Natl Cancer Inst. 2011; 103: 1037–48.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    2. Huang Z,
    3. Wen W,
    4. Zheng Y,
    5. Gao YT,
    6. Wu C,
    7. Bao P, et al.
    Breast cancer incidence and mortality: trends over 40 years among women in Shanghai, China. Ann Oncol. 2016; 27: 1129–34.
    OpenUrlCrossRefPubMed
  11. 11.↵
    2. Khalis M,
    3. El Rhazi K,
    4. Charaka H,
    5. Chajes V,
    6. Rinaldi S,
    7. Nejjari C, et al.
    Female breast cancer incidence and mortality in Morocco: comparison with other countries. Asian Pacific J Cancer Prevent. 2016; 17: 5211–6.
    OpenUrl
  12. 12.↵
    2. Zhang Y,
    3. Qu C,
    4. Ren J,
    5. Zhang S,
    6. Wang Y,
    7. Dai M.
    Liver cancer incidence and mortality data set in China. Zhonghua Zhong Liu Za Zhi Chin J Oncol. 2015; 37: 705–20.
    OpenUrl
  13. 13.↵
    2. Bray F,
    3. Guilloux A,
    4. Sankila R,
    5. Parkin DM.
    Practical implications of imposing a new world standard population. Cancer Causes Control. 2002; 13: 175–82.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    2. Knorr-Held L,
    3. Rainer E.
    Projections of lung cancer mortality in West Germany: a case study in Bayesian prediction. Biostatistics (Oxford, England). 2001; 2: 109–29.
    OpenUrlCrossRefPubMed
  15. 15.↵
    2. Schmid V,
    3. Held L.
    Bayesian extrapolation of space-time trends in cancer registry data. Biometrics. 2004; 60: 1034–42.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    2. Schmid VJ,
    3. Held L.
    Bayesian age-period-cohort modeling and prediction – BAMP. J Stat Softw. 2007; 21: 1–15.
    OpenUrlCrossRefPubMed
  17. 17.↵
    2. Ibrahim EM,
    3. Zeeneldin AA,
    4. El-Khodary TR,
    5. Al-Gahmi AM,
    6. Bin Sadiq BM.
    Past, present and future of colorectal cancer in the Kingdom of Saudi Arabia. Saudi J Gastroenterol. 2008; 14: 178–82.
    OpenUrl
  18. 18.↵
    2. Moller B,
    3. Fekjaer H,
    4. Hakulinen T,
    5. Tryggvadottir L,
    6. Storm HH,
    7. Talback M, et al.
    Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prevent. 2002; 11(Suppl 1): S1–96.
    OpenUrlCrossRefPubMed
  19. 19.↵
    2. DeSantis C,
    3. Ma J,
    4. Bryan L,
    5. Jemal A.
    Breast cancer statistics, 2013. CA: Cancer J Clin. 2014; 64: 52–62.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    2. DeSantis CE,
    3. Fedewa SA,
    4. Goding Sauer A,
    5. Kramer JL,
    6. Smith RA,
    7. Jemal A.
    Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA: Cancer J Clin. 2016; 66: 31–42.
    OpenUrlCrossRefPubMed
  21. 21.↵
    2. Lagacé F,
    3. Ghazawi FM,
    4. Le M,
    5. Rahme E,
    6. Savin E,
    7. Zubarev A, et al.
    Analysis of incidence, mortality trends, and geographic distribution of breast cancer patients in Canada. Breast Cancer Res Treat. 2019; 178: 683–91.
    OpenUrl
  22. 22.↵
    2. Zhang Q,
    3. Liu LY,
    4. Wang F,
    5. Mu K,
    6. Yu ZG,
    The changes in female physical and childbearing characteristics in China and potential association with risk of breast cancer. BMC Public Health. 2012; 12: 368.
    OpenUrlPubMed
  23. 23.
    2. Lewington S,
    3. Li L,
    4. Murugasen S,
    5. Hong LS, et al.
    Temporal trends of main reproductive characteristics in ten urban and rural regions of China: the China Kadoorie biobank study of 300,000 women. Int J Epidemiol. 2014; 43: 1252–62.
    OpenUrlCrossRefPubMed
  24. 24.
    2. Pan K,
    3. Smith LP,
    4. Batis C,
    5. Popkin BM,
    6. Kenan WR.
    Increased energy intake and a shift towards high-fat, non-staple high-carbohydrate foods amongst China’s older adults, 1991–2009. 2013; 3: 107–15.
  25. 25.↵
    2. Chen Y,
    3. Peng Q,
    4. Yang Y,
    5. Zheng S,
    6. Wang Y,
    7. Lu W.
    The prevalence and increasing trends of overweight, general obesity, and abdominal obesity among Chinese adults: a repeated cross-sectional study, BMC Public Health. 2019; 19: 1293.
    OpenUrlPubMed
  26. 26.↵
    2. Porter P.
    “Westernizing” women’s risks? Breast cancer in lower-income countries. N Engl J Med. 2008; 358: 213–6.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    2. Narod SA.
    Hormone replacement therapy and the risk of breast cancer. Nat Rev Clin Oncol. 2011; 8: 669–76.
    OpenUrlCrossRefPubMed
  28. 28.↵
    2. Zhang J,
    3. Wang H,
    4. Wang Z,
    5. Du W,
    6. Su C,
    7. Zhang J.
    Prevalence and stabilizing trends in overweight and obesity among children and adolescents in China, 2011–2015. BMC Public Health. 2018; 18: 571.
    OpenUrlCrossRefPubMed
  29. 29.↵
    2. Banister J,
    3. Bloom DE,
    4. Rosenberg L.
    Population Aging and Economic Growth in China. PGDA Working Papers, 2010.
  30. 30.↵
    Committee of Breast Cancer Society, C.A.-C. Association, China Anti-Cancer Association guidelines for breast cancer diagnosis and treatment. China Oncol. 2017; 09: 20–84.
    OpenUrl
  31. 31.↵
    2. Ravdin PM,
    3. Cronin KA,
    4. Howlader N,
    5. Berg CD,
    6. Chlebowski RT,
    7. Feuer EJ, et al.
    The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007; 356: 1670–4.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    2. Li H,
    3. Zheng RS,
    4. Zhang SW,
    5. Zeng HM,
    6. Sun KX,
    7. Xia CF, et al.
    Incidence and mortality of female breast cancer in China, 2014. Zhonghua Zhong Liu Za Zhi. 2018; 40: 166–71.
    OpenUrl
  33. 33.↵
    2. Zuo TT,
    3. Zheng RS,
    4. Zeng HM,
    5. Zhang SW,
    6. Chen WQ.
    Female breast cancer incidence and mortality in China, 2013. Thorac Cancer. 2017; 8: 214–8.
    OpenUrl
  34. 34.↵
    2. Yip CH,
    3. Cazap E,
    4. Anderson BO,
    5. Bright KL,
    6. Caleffi M,
    7. Cardoso F, et al.
    Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global Initiative. Breast (Edinburgh, Scotland). 2011; 20(Suppl 2): S12–9.
    OpenUrl
  35. 35.↵
    2. Wong IO,
    3. Kuntz KM,
    4. Cowling BJ,
    5. Lam CL,
    6. Leung GM.
    Cost effectiveness of mammography screening for Chinese women. Cancer. 2007; 110: 885–95.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    2. Sun L,
    3. Legood R,
    4. Sadique Z,
    5. Dos-Santos-Silva I,
    6. Yang L.
    Cost-effectiveness of risk-based breast cancer screening programme, China. Bull World Health Organ. 2018; 96: 568–77.
    OpenUrl
  37. 37.↵
    2. Tian YH,
    3. Yao HF.
    Analysis on screening status and desire of cervical cancer and breast cancer among 35–45-year-old rural women in Wuhan city. Matern Child Health Care China. 2016; 31: 1832–4.
    OpenUrl
  38. 38.↵
    2. Li J,
    3. Zhang BN,
    4. Fan JH,
    5. Pang Y,
    6. Zhang P,
    7. Wang SL, et al.
    A nation-wide multicenter 10-year (1999–2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer. 2011; 11: 364–74.
    OpenUrlCrossRefPubMed
  39. 39.↵
    2. Smith EC,
    3. Ziogas A,
    4. Anton-Culver H.
    Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 2013; 148: 516–23.
    OpenUrl
  40. 40.↵
    2. Wang G,
    3. Jiang X.
    Help-seeking delay by breast cancer patients in Sichuan Province. Chin J Evid-Based Med. 2007; 7: 702–5.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords